Summary of the Conference Call for 华测检测 (Huace Testing) Company Overview - **Company**: 华测检测 (Huace Testing) - **Industry**: Testing, Inspection, and Certification (TIC) Key Points 2026 Performance Guidance - The company aims for a growth of 15% or more in 2026, with approximately 5% of this growth expected from overseas acquisitions completed in Q4 2025, including SafetySA, M-Cert, and OpenView [2][20] Medical and Pharmaceutical Segment - The medical segment is anticipated to recover in 2025 and accelerate growth in 2026, benefiting from the availability of experimental monkeys and improved CRO order intake, leading to a significant reduction in losses and an increase in gross margin [2][5] - The introduction of a chief scientist in the Kunshan preclinical evaluation business is expected to help tackle major R&D challenges and attract projects [5] - The new Kunshan medical device laboratory is projected to be a core growth point, with operations starting in January 2026 [6][23] Semiconductor Testing Business - The semiconductor testing segment is expected to achieve breakeven in 2026, focusing on automotive-grade chip domestic substitution and computing chips [2][7] - The company has invested in capacity release and team optimization, with a focus on high-margin segments [7] Internationalization Strategy - The company plans to increase the proportion of overseas business to over 20% within 3-5 years, with a focus on Southeast Asia, Europe, Africa, and the Middle East [4][5] - Recent acquisitions in Greece (M-Cert) and Vietnam (OpenView) are expected to significantly contribute to overseas business growth in 2026 [4][5] Emerging Markets and New Business Areas - The smart driving sector has orders booked until mid-2026, with new business areas such as low-altitude economy, robotics, and carbon emission certification expected to drive growth in 2026 [2][5] Capital Expenditure and Dividends - The capital expenditure budget for 2026 is set at around 7% of revenue, with a stable dividend policy likely to maintain mid-term dividends [3][10][26] AI and Digitalization - The company has implemented AI technology in 37 scenarios, significantly improving operational efficiency, with some applications reducing manual review workloads by up to 80% [21] Market Conditions and Pricing Pressure - The automotive sector is facing price competition, but the company is leveraging operational efficiency to mitigate this [9][25] - The medical segment is experiencing a recovery in pricing due to a shortage of experimental monkeys and reduced competition [9] Future Growth and Strategic Focus - The company aims to maintain sustainable growth and quality, with a focus on long-term strategic investments even if they impact short-term profits [27] - The company is committed to becoming a top ten global TIC provider, emphasizing talent development and integration of diverse backgrounds [27] Financial Contributions from Acquisitions - The acquisitions of M-Cert, OpenView, and CFA S.A. are expected to contribute significantly to revenue and profit in 2026, with M-Cert and OpenView projected to grow over 20% [21][22] Environmental Business Outlook - The environmental segment is expected to see stable growth, with a focus on new projects and cost control measures [11][12] Conclusion - Overall, the company is positioned for significant growth in 2026, driven by strategic acquisitions, recovery in key segments, and a strong focus on operational efficiency and international expansion [2][20][27]

Summary of Huace Testing Conference Call Company Overview - **Company**: Huace Testing - **Recent Acquisition**: Acquired South African company Fifty to enhance overseas expansion capabilities, particularly in food safety [2][4] Key Points and Arguments Acquisition Details - The acquisition of Fifty is aimed at strengthening Huace Testing's international presence and addressing weaknesses in training services [2][4] - The acquisition will be funded through cash, with sufficient cash flow to support the transaction without the need for stock issuance [2][6] Financial Performance - Overall revenue growth target for the year remains at 10%, despite seasonal uncertainties in quarterly performance [2][7] - Last year's Q2 revenue was approximately 1.6 billion, with the Sanpu business contributing about 100 million, accounting for roughly 6% [2][8] - The food testing segment showed robust performance with nearly 10% growth last year and 15% growth in Q1 of this year, expected to maintain around 10% growth for the year [2][10] - Environmental testing projects exceeded expectations in Q1 but are expected to face pressure in Q2 due to government budget tightening [2][9] - The pharmaceutical and medical segment incurred losses last year, with a goal to reduce losses this year, although the pressure to turn profitable remains significant [2][11] Business Segment Insights - The Beisbo business is gradually improving as equipment is being installed, while the Yima business is facing challenges in the German market but performing well in the US and Mexico [2][12] - The domestic automotive market remains stable, with Huace Testing achieving high single-digit growth and improved gross margins through enhanced internal lab efficiency [2][13][18] - The CRO business in drug testing is on an upward trend, with the CMC sector doubling last year and maintaining stability this year [2][14][15] Market and Industry Trends - The testing industry is experiencing intensified price competition due to increased market saturation, impacting profitability [2][17] - Huace Testing is exploring opportunities in the African market due to its recent growth, with potential future expansions into other regions based on market conditions [2][5] Capital Expenditure and Personnel Management - Capital expenditure has been reduced from 10% to 7% of revenue, reflecting a shift in investment strategy due to market conditions [2][21] - Personnel management will continue to align with revenue growth, with an emphasis on improving employee efficiency [2][22] Future Outlook - The company is optimistic about achieving its annual performance targets, although quarterly performance may vary based on seasonal factors [2][28] - The acquisition of the South African company is expected to be consolidated in the second half of 2025, with other potential acquisitions also in progress [2][29] Additional Important Insights - The company is investing in smart driving technologies and electric motor control, aligning with industry trends [2][19] - The development of standards in smart driving technology is still in its early stages, with ongoing collaborations with automotive manufacturers [2][20] - The trade assurance segment has shown over 15% growth in Q1, largely due to acquisitions made last year [2][16]